Skip to main content

Articles

1261 result(s) for 'fasting for lipid profile' within Lipids in Health and Disease

Page 17 of 26

  1. A recent in vitro study indicates that IGOB131, a novel seed extract of the traditional West African food plant Irvingia gabonensis, favorably impacts adipogenesis through a variety of critical metabolic pathways...

    Authors: Judith L Ngondi, Blanche C Etoundi, Christine B Nyangono, Carl MF Mbofung and Julius E Oben
    Citation: Lipids in Health and Disease 2009 8:7
  2. Dietary fats have long been associated with human health, and especially cardiovascular disease (CVD). Some observational studies have shown that reduction in dietary fats, and particularly cholesterol is asso...

    Authors: Evangelos Polychronopoulos, George Pounis, Vassiliki Bountziouka, Akis Zeimbekis, Ioanna Tsiligianni, Brikena-Eirini Qira, Efthimios Gotsis, George Metallinos, Christos Lionis and Demosthenes Panagiotakos
    Citation: Lipids in Health and Disease 2010 9:30
  3. Apolipoprotein (Apo) levels are considered more reliable than plasma lipoprotein levels for predicting coronary artery disease (CAD). However, a unanimous Apo marker for CAD has not been identified. In the Chi...

    Authors: Po-Yuan Chang, Chii-Ming Lee, Hsiu-Ching Hsu, Hung-Ju Lin, Kuo-Liong Chien, Ming-Fong Chen, Chu-Huang Chen, Yuan-Teh Lee and Chao-Yuh Yang
    Citation: Lipids in Health and Disease 2012 11:162
  4. To study the role of gene mutations in the development of severe hypertriglyceridemia (HTG) in patients with hyperlipidemic acute pancreatitis (HLAP), especially different apolipoprotein A5 (APOA5) mutations.

    Authors: Yuxin Liu, Si Dai, Shuqi Qin, Jing Zhou, Zhendan Wang and Guojian Yin
    Citation: Lipids in Health and Disease 2024 23:44
  5. Aspirin and eugenol were esterified to synthesize aspirin eugenol ester (AEE). As a pale yellow and odourless crystal, AEE reduced the gastrointestinal damage of aspirin and vulnerability of eugenol. The study...

    Authors: Isam Karam, Ning Ma, Xi-Wang Liu, Xiao-Jun Kong, Xiao-Le Zhao, Ya-Jun Yang and Jian-Yong Li
    Citation: Lipids in Health and Disease 2016 15:196
  6. Non-alcoholic fatty liver disease (NAFLD) is a continuum of diseases that include simple steatosis and non-alcoholic steatohepatitis (NASH) ultimately leading to cirrhosis, hepatocellular carcinoma and end sta...

    Authors: Irina Voloshin, Michal Hahn-Obercyger, Sarit Anavi and Oren Tirosh
    Citation: Lipids in Health and Disease 2014 13:69
  7. Leptin acts as a mediator of inflammation and energy homeostasis by activating leptin receptor (LEPR). We conducted this study to explore the association of polymorphisms in LEPR with type 2 diabetes mellitus (T2...

    Authors: Lulu Zhang, Yingfen Qin, Danyan Liang, Li Li, Yaojie Liang, Lulin Chen, Lei Tong, Jia Zhou, Hong Li and Haiying Zhang
    Citation: Lipids in Health and Disease 2018 17:2
  8. Hepatic lipid accumulation is closely related to the development of insulin resistance, which is regarded as one of the most significant risk factors of nonalcoholic fatty liver disease (NAFLD). Although the e...

    Authors: Natalia Wasilewska, Anna Bobrus-Chociej, Ewa Harasim-Symbor, Eugeniusz Tarasów, Małgorzata Wojtkowska, Adrian Chabowski and Dariusz M. Lebensztejn
    Citation: Lipids in Health and Disease 2018 17:216
  9. High serum NEFA and GDF-15 are risk factors for CAD and have been linked to detrimental cardiovascular events. It has been hypothesized that hyperuricemia causes CAD via the oxidative metabolism and inflammati...

    Authors: Jingru Cheng, Yongnan Lyu, Yufeng Mei, Qian Chen, Hang Liu and Yan Li
    Citation: Lipids in Health and Disease 2023 22:31
  10. We conducted a secondary analysis of serum samples and birth outcome data from healthy pregnant women (N = 25) with mid-pregnancy fasting serum samples collected at 22–28 weeks of gestation. Serum was analyzed for

    Authors: Todd C. Rideout, Jaclyn Wallace, Xiaozhong Wen, Vanessa M. Barnabei, Kai Ling Kong and Richard W. Browne
    Citation: Lipids in Health and Disease 2023 22:37
  11. This trial compares the efficacy of administering a combination of ezetimibe plus fenofibrate as an alternative to statin monotherapy for the treatment of dyslipidemia. In this randomized, unblinded crossover ...

    Authors: Shoba Sujana Kumar, Karen A Lahey, Andrew Day and Stephen A LaHaye
    Citation: Lipids in Health and Disease 2009 8:56
  12. Maresin-1 (MaR1) is an anti-inflammatory pro-resolving mediator and is considered a potential regulator of metabolic diseases. Non-alcoholic fatty liver disease (NAFLD) is a very common metabolic liver disease...

    Authors: Xia Fang, Hongya Wang, Ting Ye, Xiaolan Fu, Xiaozhen Tan, Yan Zeng, Jiahao Fan and Yong Xu
    Citation: Lipids in Health and Disease 2021 20:96
  13. Fragarianilgerrensis Schlecht. medicine compound (FN-MC) is a kind of Chinese herbs’ compound consisted of Fragarianilgerrensis Schlecht. and Centella asiatica (L.) Urban. The study was to investigate the hypolip...

    Authors: Liangcai Gao, Zejie Lin, Yilian Liu, Xinyi Wang, Linlin Wan, Liuliu Zhang and Xinnan Liu
    Citation: Lipids in Health and Disease 2018 17:222
  14. Apolipoprotein E (apoE) is a key component of the lipid metabolism. Polymorphisms at the apoE gene (APOE) have been associated with cardiovascular disease, lipid levels and lipid-lowering response to statins. We ...

    Authors: Alvaro Cerda, Fabiana DV Genvigir, Maria AV Willrich, Simone S Arazi, Marcia MS Bernik, Egidio L Dorea, Marcelo C Bertolami, Andre A Faludi, Mario H Hirata and Rosario DC Hirata
    Citation: Lipids in Health and Disease 2011 10:206
  15. The expression of some genes controlling energy homeostasis could be regulated by epigenetic mechanisms that may play a role in body weight regulation. Thus, it is known that various nutritional factors affect...

    Authors: Almudena Lomba, Fermín I Milagro, Diego F García-Díaz, Amelia Marti, Javier Campión and J Alfredo Martínez
    Citation: Lipids in Health and Disease 2010 9:60
  16. Ezetimibe (Zetia®) is a potent inhibitor of cholesterol absorption that has been approved for the treatment of hypercholesterolemia. Statin, an inhibitor of cholesterol synthesis, is the first-choice drug to redu...

    Authors: Minako Yamaoka-Tojo, Taiki Tojo, Rie Kosugi, Yuko Hatakeyama, Yuki Yoshida, Yoji Machida, Naoyoshi Aoyama, Takashi Masuda and Tohru Izumi
    Citation: Lipids in Health and Disease 2009 8:41
  17. Melatonin (N-acetyl-5-methoxytryptamine, MLT) is a neuroendocrine hormone, which is primarily synthesized by the pineal gland in vertebrates. Melatonin is a remarkable molecule with diverse biological and phys...

    Authors: Hang Sun, Fang-fang Huang and Shen Qu
    Citation: Lipids in Health and Disease 2015 14:75
  18. The lipoprotein lipase (LPL) hydrolyses circulating triacylglycerol-rich lipoproteins. Thereby, LPL acts as a metabolic gate-keeper for fatty acids partitioning between adipose tissue for storage and skeletal ...

    Authors: Florence Gondret, Sanjay B Jadhao, Marie Damon, Patrick Herpin, Céline Viglietta, Louis-Marie Houdebine and Jean-François Hocquette
    Citation: Lipids in Health and Disease 2004 3:27
  19. Type 2 Diabetes (T2D) is influenced by genetic, environmental, and ageing factors. Ageing pathways exacerbate metabolic diseases. This study aimed to examine both clinical and genetic factors of T2D in older a...

    Authors: Siobhán O.’ Sullivan, Cynthia Al Hageh, Andreas Henschel, Stephanie Chacar, Antoine Abchee, Pierre Zalloua and Moni Nader
    Citation: Lipids in Health and Disease 2024 23:56
  20. Apolipoprotein E (APOE) plays a major role in lipid metabolism and inflammation. However, the association between APOE gene polymorphisms and serum triglyceride levels remains controversial. We tested the effects...

    Authors: Semon Wu, Lung-An Hsu, Ming-Sheng Teng, Jeng-Feng Lin, Hsin-Hua Chou, Ming-Cheng Lee, Yi-Ming Wu, Cheng-Wen Su and Yu-Lin Ko
    Citation: Lipids in Health and Disease 2016 15:94
  21. Non-alcoholic fatty liver disease (NAFLD) is a public health problem lacking an approved pharmacological treatment. Omega-3 fatty acids have shown to reverse NAFLD. Chia is a seed rich in α-linolenic acid (ALA...

    Authors: Aida Medina-Urrutia, Angel R. Lopez-Uribe, Mohamed El Hafidi, Maria del Carmen González-Salazar, Rosalinda Posadas-Sánchez, Esteban Jorge-Galarza, Leonardo del Valle-Mondragón and Juan G. Juárez-Rojas
    Citation: Lipids in Health and Disease 2020 19:96
  22. Previously, we found a significant relationship in a rat study between energy intake and bile acid (BA) metabolism especially 12α-hydroxylated (12αOH) BAs. The present study was designed to reveal relationship...

    Authors: Reika Yoshitsugu, Keidai Kikuchi, Shota Hori, Hitoshi Iwaya, Masahito Hagio, Hidehisa Shimizu, Tohru Hira and Satoshi Ishizuka
    Citation: Lipids in Health and Disease 2020 19:9
  23. A considerable number of patients with severely elevated LDL-C do not achieve recommended treatment targets, despite treatment with statins. Adults at high cardiovascular risk with hypercholesterolemia and LDL...

    Authors: Paul Kah Hing Ling, Fernando Civeira, Andrei Gheorghe Dan, Mary E Hanson, Rachid Massaad, Celine Le Bailly De Tilleghem, Christopher Milardo and Joseph Triscari
    Citation: Lipids in Health and Disease 2012 11:18
  24. Ceramide plays pathogenic roles in nonalcoholic fatty liver disease (NAFLD) via multiple mechanisms, and as such inhibition of ceramide de novo synthesis in the liver may be of therapeutically beneficial in pa...

    Authors: Rui-Xu Yang, Qin Pan, Xiao-Lin Liu, Da Zhou, Feng-Zhi Xin, Ze-Hua Zhao, Rui-Nan Zhang, Jing Zeng, Liang Qiao, Chun-Xiu Hu, Guo-Wang Xu and Jian-Gao Fan
    Citation: Lipids in Health and Disease 2019 18:179
  25. There is an urgent need to learn more about the epidemiological features of dyslipidemia in youth to address the high burden of cardiovascular disease.

    Authors: Liang-Yu Liu, Xiyidan Aimaiti, Ying-Ying Zheng, Xiao-Yu Zhi, Zhi-Long Wang, Xin Yin, Ying Pan, Ting-Ting Wu and Xiang Xie
    Citation: Lipids in Health and Disease 2023 22:108
  26. Recently, trimethylamine-N-oxide (TMAO) plasma levels have been proved to be associated with atherosclerosis development. Among the targets aimed to ameliorating atherosclerotic lesions, inducing bile acid syn...

    Authors: Lin Ding, Mengru Chang, Ying Guo, Lingyu Zhang, Changhu Xue, Teruyoshi Yanagita, Tiantian Zhang and Yuming Wang
    Citation: Lipids in Health and Disease 2018 17:286
  27. Bitter melon (BM, Momordica charantia) has been accepted as an effective complementary treatment of metabolic disorders such as diabetes, hypertension, dyslipidemia and etc. However it is unclear whether BM ca...

    Authors: Yanmei Zeng, Meiping Guan, Chenzhong Li, Lingling Xu, Zhongji Zheng, Jimin Li and Yaoming Xue
    Citation: Lipids in Health and Disease 2018 17:251
  28. Intensive-insulin treatment (IIT) strategy for patients with type 1 diabetes mellitus (T1DM) has been associated with sedentary behaviour and the development of insulin resistance. Exercising patients with T1D...

    Authors: David P. McBey, Michelle Dotzert and C. W. J. Melling
    Citation: Lipids in Health and Disease 2021 20:64
  29. Thymus algeriensis Boiss. et Reut. (Lamiaceae), popularly known as “mougecha” or “mazoukcha” is prolific in Mediterranean regions, mostly in North Africa, and is used in folk medicine to treat of stomach diseases...

    Authors: Fatma Guesmi, Manel Ben Ali, Taha Barkaoui, Wiem Tahri, Mondher Mejri, Mossadok Ben-Attia, Houda Bellamine and Ahmed Landoulsi
    Citation: Lipids in Health and Disease 2014 13:138
  30. “Residual skin surface components” (RSSC) is the collective term used for the superficial layer of sebum, residue of sweat, small quantities of intercellular lipids and components of natural moisturising facto...

    Authors: Satyajit S. Shetage, Matthew J. Traynor, Marc B. Brown and Robert P. Chilcott
    Citation: Lipids in Health and Disease 2018 17:194
  31. Inflammation is a common feature in the majority of cardiovascular disease, including Diabetes Mellitus (DM). Levels of pro-inflammatory markers have been found in increasing levels in serum from diabetic pati...

    Authors: Antonio Gordillo-Moscoso, Emilio Ruiz, Manuel Carnero, Fernando Reguillo, Enrique Rodriguez, Teresa Tejerina and Santiago Redondo
    Citation: Lipids in Health and Disease 2013 12:62
  32. Dyslipidemia is a significant contributor to cardiovascular and cerebrovascular diseases. Research on the relationship between breakfast consumption frequency and dyslipidemia in the working population is lack...

    Authors: Qi-mei Li, Cheng-kai Wu, Peng-cheng Ma, Hao Cui, Rui-ning Li, Chang Hong, Lin Zeng, Sheng-wu Liao, Lu-shan Xiao, Li Liu and Wen-yuan Li
    Citation: Lipids in Health and Disease 2022 21:33
  33. The weakening of the cardiovascular system associated with aging could be countered by increasing levels of physical activity and functional fitness. However, inconsistent findings have been found, and the var...

    Authors: Raul A Martins, Manuel T Veríssimo, Manuel J Coelho e Silva, Sean P Cumming and Ana M Teixeira
    Citation: Lipids in Health and Disease 2010 9:76
  34. Clinical investigations have found that there was a close association between T2DM and adverse cardiovascular events, with possible mechanisms included inflammation, apoptosis, and lipid metabolism disorders. ...

    Authors: Yufeng Mei, Zhiming Zhao, Yongnan Lyu and Yan Li
    Citation: Lipids in Health and Disease 2022 21:59
  35. Acanthosis nigricans (AN) has a close relationship with obesity. It is believed that obesity and AN have the common pathophysiological basis such as hyperinsulinism. This study is aimed to observe the effect o...

    Authors: Yi Zhang, Cuiling Zhu, Xin Wen, Xingchun Wang, Liang Li, Sharvan Rampersad, Liesheng Lu, Donglei Zhou, Chunhua Qian, Ran Cui, Manna Zhang, Peng Yang, Shen Qu and Le Bu
    Citation: Lipids in Health and Disease 2017 16:209
  36. Dyslipidemia is an important independent modifiable risk factor for cardiovascular disease. The aim of this study was to explore the current prevalence, awareness, treatment and control of dyslipidemia and its...

    Authors: Fu-Liang Zhang, Ying-Qi Xing, Yan-Hua Wu, Hao-Yuan Liu, Yun Luo, Ming-Shuo Sun, Zhen-Ni Guo and Yi Yang
    Citation: Lipids in Health and Disease 2017 16:61
  37. Lipoprotein (a) [Lp(a)] is a proven independent risk factor for coronary heart disease. It is also associated with type 2 diabetes mellitus (T2DM). However, the correlation between Lp(a) and T2DM has not been ...

    Authors: Qingan Fu, Lijuan Hu, Yuan Xu, Yingping Yi and Long Jiang
    Citation: Lipids in Health and Disease 2021 20:76
  38. Achilles tendons are the most common sites of tendon xanthomas that are commonly caused by disturbance of lipid metabolism. Achilles tendon thickening is the early characteristic of Achilles tendon xanthomas. ...

    Authors: Bei Wang, Qiuwang Zhang, Ling Lin, Li-li Pan, Cheng-yu He, Xiang-xin Wan, Zhi-ang Zheng, Zheng-xin Huang, Chao-bao Zou, Ming-chang Fu and Michael J. Kutryk
    Citation: Lipids in Health and Disease 2018 17:131
  39. Lowering plasma low density lipoprotein-cholesterol (LDL-C), blood pressure, homocysteine, and preventing platelet aggregation using a combination of a statin, three blood pressure lowering drugs such as a thi...

    Authors: Undurti N Das
    Citation: Lipids in Health and Disease 2008 7:37
  40. The aim of this study was to determine the physiological effects of an high-intensity circuit training (HICT) on several cardiovascular disease risk factors in healthy, overweight middle-aged subjects, and to ...

    Authors: Antonio Paoli, Quirico F Pacelli, Tatiana Moro, Giuseppe Marcolin, Marco Neri, Giuseppe Battaglia, Giuseppe Sergi, Francesco Bolzetta and Antonino Bianco
    Citation: Lipids in Health and Disease 2013 12:131
  41. NPC1L1 encodes a putative intestinal sterol transporter which is the likely target for ezetimibe, a new type of lipid-lowering medication. We previously reported rare non-synonymous mutations in NPC1L1 in an indi...

    Authors: Robert A Hegele, Justin Guy, Matthew R Ban and Jian Wang
    Citation: Lipids in Health and Disease 2005 4:16
  42. Asymmetric Dimethylarginine (ADMA) is an inhibitor of endogenous nitric oxide synthase, which is the key synthase for nitric oxide (NO) production. Whether statins could protect endothelium by reducing ADMA co...

    Authors: Dongdan Zheng, Qing Liang, FanFang Zeng, Zhuocheng Mai, Anping Cai, Ruofeng Qiu, Rulin Xu, Dongjuan Li and Weiyi Mai
    Citation: Lipids in Health and Disease 2015 14:41
  43. A high-fat diet (HFD) is known to lead to obesity, and contributes to the progression of non-alcoholic fatty liver disease. The objective of this study was to evaluate the effects of sleeve gastrectomy (SG) on...

    Authors: Erli Pei, Yang Liu, Weiqing Jiang, Songruo Lin, Lei Huang, Moubin Lin and Li Cai
    Citation: Lipids in Health and Disease 2018 17:243

Annual Journal Metrics

  • 2022 Citation Impact
    4.5 - 2-year Impact Factor
    4.9 - 5-year Impact Factor
    1.358 - SNIP (Source Normalized Impact per Paper)
    1.042 - SJR (SCImago Journal Rank)

    2023 Speed
    2 days submission to first editorial decision for all manuscripts (Median)
    68 days submission to accept (Median)

    2023 Usage 
    1,810,907 downloads
    1,488 Altmetric mentions